16545-68-9Relevant articles and documents
-
DePuy,C.H. et al.
, p. 3616 - 3617 (1961)
-
ENZYMATIC HYDROLYSIS OF CYCLOPROPYL ACETATE, A FACILE METHOD FOR MEDIUM- AND LARGE-SCALE PREPARATIONS OF CYCLOPROPANOL
Jongejan, Jaap A.,Duine, Johannis A.
, p. 2767 - 2768 (1987)
Enzymatic hydrolysis of cyclopropyl acetate at neutral pH, using commercially available enzyme preparations, results in a mixture from which cyclopropanol can be isolated by simple extraction.
SELECTIVE POTASSIUM CHANNEL AGONISTS
-
Page/Page column 32-33, (2019/11/12)
Selective potassium channel agonists and methods of use thereof are disclosed. A compound, or a pharmaceutically acceptable salt thereof, having a formula (I) wherein R1 is H or optionally-substituted alkyl; R2 is optionally-substituted C1-C6 alkyl or optionally- substituted cyclopropyl; R3 and R4 are each independently H or optionally- substituted alkyl; R5 is H, optionally-substituted alkyl, acyl, or alkoxycarbonyl; R6 and R7 are each independently H, optionally- substituted alkyl, or R6 and R7 together form a carbocycle; R8 is substituted phenyl or optionally-substituted pyridinyl, provided that if R8 is substituted phenyl, then R2 is optionally-substituted cyclopropyl; and R9, R10 and R11 are each independently H, halo, or optionally- substituted alkyl.
ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF
-
Paragraph 0103; 0104; 0105, (2017/04/18)
An ALK kinase inhibitor compound as represented by Formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the preparation of drugs serving as an ALK inhibitor for treating cancer.
